Lithium and Mood Stabilizers Flashcards
Lithium
Indications
-
Acute Mania
- Takes days to weeks to achieve effect so used along with other agents
-
Prevention of recurrent bipolar affective illness especially manic episodes
- Not considered as good for rapid cycling or mixed episodes
- Severe recurrent depression with cyclic pattern
- Sometimes combined with antipsychotic drugs to treat psychosis
- Unipolar depression that do not respond to antidepressants, who may actually be bipolar
Therapeutic concentrations of lithium ⇒ almost no discernible psychotropic effect in normal control humans
Differentiates lithium from all other psychoactive drugs
Lithium
Absorption & Distribution
-
Absorption
- Almost completely absorbed from GI tract
- Available in extended-release tablet to prolong action
-
Distribution
- Distributed in ECF with gradual accumulation in various tissues to different degrees
- Final volume of distribution approaches total body water
- Lithium slowly passes through the BBB ⇒ at steady-state, CSF concentrations ≈ 40% of plasma
Lithium
Metabolism & Excretion
-
~ 95% of a single dose is eliminated in the urine
- T½ = 20-24 hrs
-
Repeated doses ⇒ shortens T½
- After one-year, T½ = 2.4 days
- Shorter T½ in geriatric pts and pts w/ impaired renal function
- Considerable pharmacokinetic variations b/t pts but relatively stable w/in pts
-
Low therapeutic index ⇒ high risk of toxicity
- Requires regular monitoring of blood drug concentrations
- Anything that ↑ renal salt absorption from proximal tubule ⇒ ↑ lithium absorption
- Avoid dehydration ⇒ ↑ lithium in the serum
- Excess Na+ ⇒ ↑ elimination of lithium
- ↓ Na+ ⇒ ↓ elimination of lithium
-
Optimal serum concentration: 0.6-1.3 mEq/L [measured 10 hours after PO dose]
- Lower doses may be used when combined with other agents
- Titration to higher doses under very close supervision, generally in-patient
Lithium
Mechanism of Action
Exact mechanism unknown
Several proposed mechanisms:
-
⊗ Inositol monophosphatase
- ↓ brain inositol ⇒ ⊗ receptor-activated PIP3 hydrolysis ⇒ ⊗ formation of inositol-1,4,5-triphosphate (IP3) and diacylglycerol (DAG)
- Depletion of phosphoinositide precursors ∝ activity of the cell (or PLC)
- Mania may be associated with a state of neuronal hyperactivity ⇒ lithium may selectively inhibit these pathways
-
⊗ G-protein coupled receptors
- ⊗ NE stimulated adenylyl cyclase
- ⊗ some G-protein coupled receptors
- Leads to one major and one minor side effect
- ⊗ vasopressin (ADH) leads to polyuria
- ⊗ TSH leads to subclinical hypothyroidism
-
⊗ Growth factor pathways
- GF acts via glycogen synthase kinase (GSK-3) ⇒ ⊕ cell death
- Lithium ⊗ GSK-3 ⇒ neuroprotective effects and long-term plasticity
Lithium
Toxic Reactions & Side Effects
-
CNS
Sx can occur @ therapeutic doses but if more severe or > 1 occurs ⇒ indication of toxicity- Tremor - frequent, occurs at peak blood levels after therapeutic doses
- Sedation
- ↓ cognition
- Incoordination
-
Thyroid
- Lithium is concentrated in the thyroid gland
- Causes ↓ thyroid function in most pts
- Effects are reversible
- Monitor TSH levels every 6-12 months
-
Polydipsia & polyuria
-
Nephrogenic diabetes insipidus (common)
- ⊗ adenylate cyclase ⇒ ↓ aquaporin 2 channels @ apical membrane of the collecting tubules
-
Nephrogenic diabetes insipidus (common)
-
Other side effects
-
Tubulointerstial nephropathy w/ chronic Li+ treatment
- Monitor plasma creatinine and urine volume
-
Nausea, vomiting, diarrhea, weight gain
- Edema may cause weight gain but does not account for weight ∆ observed in up to 30% pts taking lithium
- Dermatitis, exacerbation of psoriasis, hair loss, and acne
-
Reversible ↑ in polymorphonuclear leukocytes w/ chronic Li+ treatment
- Can be exploited to treat low leukocyte states
-
Tubulointerstial nephropathy w/ chronic Li+ treatment
Nephrogenic Diabetes Insipidus
Treatment
Nephrogenic diabetes insipidus (common)
⊗ adenylate cyclase ⇒ ↓ aquaporin 2 channels @ apical membrane of the collecting tubules
- Resistant to vasopressin
- Paradoxically amiloride and/or thiazide diuretics can be used to tx polyuria
- MOA is unclear but may be due to ↓ ECF volume & ↑ reabsorption of Na+ and water in the proximal tubule
- Some evidence that thiazide diuretic may ↑ aquaporin 2 levels
- Thiazide diuretics ↓ lithium clearance ⇒ need to adjust lithium dose down
Lithium Use During Pregnancy
- May be used in pregnancy
- ? association between lithium use during 1st trimester and cardiovascular malformations such as Ebstein’s anomaly in neonates
- Congenital defect in the tricuspid valve
-
Absolute risk is still low
- Some clinicians consider it to be relatively safe during pregnancy
- Possible alternative would be a typical antipsychotic
- Clearance of lithium ↑ during pregnancy
Li+ Overdose
- Possible symptoms are: convulsions, coma, confusion, coarse hand tremor, muscle rigidity, fasciculations, and ataxia
-
Therapeutic overdose due to lithium accumulation
- Diuretics ⇒ ↓ serum Na+ ⇒ ↓ lithium clearance
- Changes in renal function or pregnancy
- Values of 2 meq/L in serum indicate potential toxicity
-
Treatment:
- Hemodialysis is effective if toxicity is severe with significant CNS side effects and renal impairment
- In more mild toxicity, treat with fluids
Lithium
Drug Interactions
- Lithium is often used in combo with haloperidol ⇒ may produce more extrapyramidal symptoms
- Use atypicals instead
- Diuretics, NSAIDS, ACE inhibitors ⇒ ↓ clearance of Lithium
Valproate
Indications as a Mood Stabilizer
- Acute manic phase
- Maintenance, prevention of recurrence of mania
- May be good for rapid cycling or mixed episodes
- In practice, combo of agents may be required (ex. Lithium + valproate)
Carbamazepine
Indications as a Mood Stabilizer
- 2nd line agent when pt cannot tolerate or does not respond to lithium
- Acute mania
- Maintenance, prevention of recurrence of mania
Lamotrigine
Indications as a Mood Stabilizer
- Maintenance, prevention of recurrence of both mania and depression
- Unique effect on depressed phase & preventing recurrence of depression
- Anti-depressants can unmask mania ⇒ mood instability
- Some clinicians use lamotrigine as replacement for antidepressants
Atypical Antipsychotics
Indications as a Mood Stabilizer
Use in bipolar disorder:
-
May be used alone for acute mania
- Atypicals preferred over typicals
-
May be used w/ Lithium for acute mania
- To achieve therapeutic goal more rapidly
- Olanzapine and aripiprazole approved for maintenance
- Atypicals may be used w/ other agents for maintenance